ibandronic acid has been researched along with caprylates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, D; Bilder, GE; Cornell, SA; Perrone, MH | 1 |
| Ahmed, H; Bittner, B; Chokshi, H; Fotaki, N; Infeld, M; Jordan, P; Ma, H; McIntyre, C; Phuapradit, W; Portron, A; Schmidt, J; Shah, N; Tang, K; Tian, H | 1 |
1 trial(s) available for ibandronic acid and caprylates
| Article | Year |
|---|---|
Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).
Topics: Administration, Oral; Adolescent; Adult; Algorithms; Analysis of Variance; Area Under Curve; Bone Density Conservation Agents; Caprylates; Chemistry, Pharmaceutical; Cohort Studies; Cross-Over Studies; Diphosphonates; Drug Delivery Systems; Excipients; Female; Half-Life; Humans; Ibandronic Acid; Male; Middle Aged; Solubility; Young Adult | 2012 |
1 other study(ies) available for ibandronic acid and caprylates
| Article | Year |
|---|---|
1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
Topics: Animals; Bone Resorption; Caprylates; Cell Line; Cell-Free System; Cholesterol; Diphosphonates; Farnesyl-Diphosphate Farnesyltransferase; Ibandronic Acid; Lanosterol; Mevalonic Acid; Mice; Microsomes, Liver; Rats | 1996 |